News

Abbreviated MRI breast cancer screening protocol accurate

Publish date: September 9, 2013

 

AT THE ASCO BREAST CANCER SYMPOSIUM

Dr. Kuhl has been a consultant to Bayer. She reported no other relevant financial disclosures.

*This story was updated 10/16/2013.

sboschert@frontlinemedcom.com

On Twitter @sherryboschert

Pages

Recommended Reading

BOLERO-3: Everolimus tweaks trastuzumab-resistant metastatic breast cancer
MDedge Internal Medicine
The 'Jolie effect' on BRCA risks
MDedge Internal Medicine
Updated guideline urges discussion of breast cancer chemoprevention
MDedge Internal Medicine
Racial discrepancy in breast cancer survival examined
MDedge Internal Medicine
Guidelines issued on radiation-induced heart disease
MDedge Internal Medicine
Age does not impact survival in HER2-positive breast cancer
MDedge Internal Medicine
Long-term CCB therapy linked to higher breast cancer risk
MDedge Internal Medicine
Adjuvant ibandronate adds no benefit in early stage, node-positive breast cancer
MDedge Internal Medicine
No increase in cardiovascular risk seen after radiation therapy for DCIS
MDedge Internal Medicine
Most women misestimate their breast cancer risk
MDedge Internal Medicine